Exploring the prevalence and characteristics of human epidermal growth factor receptor 2 (HER2) alterations in non-small cell lung cancer: Analysis from a Malaysian cohort

被引：0
|
作者：
Yap, N. Y. [1 ]
Perumal, K. [1 ]
Rajadurai, P. [2 ]
机构：
[1] SJMC Sime Darby Med Ctr Subang Jaya, Lab, Subang Jaya, Malaysia
[2] Subang Jaya Med Ctr, Pathol, Subang Jaya, Malaysia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.665
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
587P
引用
收藏
页码：S1699 / S1700
页数：2
相关论文
共 50 条
  • [1] Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer
    Gregorc, V
    Ceresoli, GL
    Floriani, I
    Spreafico, A
    Bencardino, KB
    Ludovini, V
    Pistola, L
    Mihaylova, Z
    Tofanetti, FR
    Ferraldeschi, M
    Torri, V
    Cappuzzo, F
    Crinò, L
    Tonato, M
    Villa, E
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6006 - 6012
  • [2] Targeting HER2 genomic alterations in non-small cell lung cancer
    Zeng, Jie
    Ma, Weijie
    Young, Richard Benjamin
    Li, Tianhong
    JOURNAL OF THE NATIONAL CANCER CENTER, 2021, 1 (02): : 58 - 73
  • [3] Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea
    Lee, Kangkook
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahm, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2020, 52 (01): : 292 - 300
  • [4] Molecular Characteristics of HER2 Mutations in Non-Small Cell Lung Cancer
    Wei, X.
    Gao, X.
    Zhang, X.
    Chen, Z.
    Wu, Y.
    Zhou, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S848 - S849
  • [5] A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients With Non-Small-Cell Lung Cancer
    Govindan, Ramaswamy
    CLINICAL LUNG CANCER, 2010, 11 (01) : 8 - 12
  • [6] The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer
    Nagasaka, Misako
    Singh, Vijendra
    Baca, Yasmine
    Sukari, Ammar
    Kim, Chul
    Mamdani, Hirva
    Spira, Alexander, I
    Uprety, Dipesh
    Bepler, Gerold
    Kim, Edward S.
    Raez, Luis E.
    Pai, Sachin Gopalkrishna
    Ikpeazu, Chukwuemeka
    Oberley, Matthew
    Feldman, Rebecca
    Xiu, Joanne
    Korn, W. Michael
    Wozniak, Antoinette J.
    Borghaei, Hossein
    Liu, Stephen, V
    CLINICAL LUNG CANCER, 2022, 23 (01) : 52 - 59
  • [7] Screening for HER2 alterations and HER2-targeted therapy in non-small cell lung cancer
    Kinoshita, Ichiro
    ANNALS OF ONCOLOGY, 2015, 26 : 40 - 40
  • [8] Epidermal growth factor receptor in non-small cell lung cancer
    Prabhakar, Charles N.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 110 - 118
  • [9] The human epidermal growth factor receptor 2 (HER2)
    Tafe, Laura J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 23 - 30
  • [10] Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations
    Xiaoli Zhuo
    Honglin Guo
    Jun Ma
    Jingjiang Lai
    Lei Liu
    Ke Yin
    Jing Zhao
    Jingliang Wang
    Fengxian Jiang
    Wei Xu
    Xiaotian Yuan
    Xiaoyan Lin
    Guobin Fu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2029 - 2039
12345